NEUROPHET, Inc.

NEUROPHET, Inc. is a neuroscience company that develops medical artificial intelligence solutions for brain science and brain diseases. Its products include Neurophet AQUA, AI-powered diagnostic assistant software for brain diseases; Neurophet SCALE PET, software that quantitatively analyzes biomarkers targeted by a specific radiotracer using PET; Neurophet tES LAB, AI-powered software that generates a 3D model from brain MRI and simulates electrical stimulation for treatment planning; and Neurophet innk, a non-invasive electrical stimulation device designed to support functional recovery and rehabilitation in patients with brain diseases. The company also provides consulting services for design systems and quality management systems, and has a strategic collaboration with VHIR Vall d'Hebron Institut de Recerca to develop AI algorithms that detect multiple sclerosis lesions using MRI data. Founded in 2016, it is headquartered in Seoul, South Korea.